• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Admin

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

Favorite Forum Topics

  • Oh, bother! No topics were found here.

Primary Sidebar

Advocacy

  • Advocacy Toolkit

Approved Drugs

  • Nuedexta
  • Radicava/Edaravone
  • Riluzole/Tiglutik
  • Rozebalamin / Methylcobalamin
  • Tofersen/Qalsody

Drugs in Development

  • AB Science – Masitinib
  • NurOwn
  • Clene Nanomedicine – CNM-Au8
  • ILB
  • Kadimastem – AstroRx
  • Neuronata-R / Lenzumestrocel
  • NeuroSense – PrimeC
  • NP001
  • Prilenia Therapeutics – Pridopidine
  • SOD1 Therapies & Trials
  • SPG302
  • Regulatory T Cell Enhancing Therapies
  • Ulefnersen

Care services

  • Genetic Counselling & Testing
  • Mental Health Support
  • Nursing and Symptom Management
  • Nutrition and Swallowing
  • Occupational Therapy and Activities of Daily Living
  • Physiotherapy and Mobility
  • Respiratory Care
  • Speech Therapy and Communication
  • Support for Family & Caregivers
  • Technology

Support for members

  • Alliance Support Grant
  • About the meetings

Events/Programs

  • Calendar of Events/Programs
  • Alliance Webinars
  • Alliance Meeting
  • Allied Professionals Forum
  • ALS/MND Connect
  • Global Day Calendar
  • March of Faces
  • International Symposium

About

  • Who We Are
  • Board of Trustees
  • Councils, Forums & Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Newsletter Archive
    • Newsletters
    • Meetings
  • Awards

Upcoming Events

Sep 22
2:00 pm - 3:00 pm EDT

ALS Association Webinar: Affordable Tools for Everyday Independence

Sep 24
1:00 pm - 2:00 pm EDT

Les Turner ALS Foundation: Cognitive and Language Impairments in ALS & ALS-FTD

Oct 13
8:00 am - 9:00 am EDT

Member Forum: Technology Solutions for PALS

Oct 13
6:00 pm - 7:00 pm EDT

Member Forum: Technology Solutions for PALS

Oct 15
9:00 am - 10:00 am EDT

Webinar: The Use of AI in ALS/MND

View Calendar

  • Joanne Pratt, Australia

    Joanne Pratt, Australia

  • Maurice Leclerc, Canada

    Maurice Leclerc, Canada

  • Kirsten Harley, Australia

    Kirsten Harley, Australia

  • Lee Millard, England

    Lee Millard, England

  • Feng Gin Sun, China

    Feng Gin Sun, China

  • Bjarne Hytjanstorp, Norway

    Bjarne Hytjanstorp, Norway

  • Mauril Belanger, Canada

    Mauril Belanger, Canada

  • Dr. Shelly Hoover, USA

    Dr. Shelly Hoover, USA

  • Sanjay Kumar Srivastava, India

    Sanjay Kumar Srivastava, India

  • Sharon Corosanite, USA

    Sharon Corosanite, USA

  • Ali Var, Turkey

    Ali Var, Turkey

  • Danny Reviers, Belgium

    Danny Reviers, Belgium
    DannyReviers

  • Eric Von Schaumburg, USA

    Eric Von Schaumburg, USA

  • Ian Roberts, Australia

    Ian Roberts, Australia

  • Mauril Bélanger, Canada

    Mauril Bélanger, Canada

  • Seckin McGuirk, England

    Seckin McGuirk, England

  • Wendy Hendrickson, USA

    Wendy Hendrickson, USA

  • Valdomiro Xavier Honório, Brazil

    Valdomiro Xavier Honório, Brazil

  • Joy Blakeley, Australia

    Joy Blakeley, Australia

  • Ailsa Malcolm-Hutton, UK

    Ailsa Malcolm-Hutton, UK

  • Conny van der Meijden, Netherlands

    Conny van der Meijden, Netherlands

  • Dr. Janmejay Pradhan, India

    Dr. Janmejay Pradhan, India

  • Jorge Luis Fernández Romero, Mexico

    Jorge Luis Fernández Romero, Mexico

  • Ana María Zavala, Mexico

    Ana María Zavala, Mexico

  • Carlos Gomez Matallanas, Spain

    Carlos Gomez Matallanas, Spain

  • Brian Parsons, Canada

    Brian Parsons, Canada

  • Graham Johnson, Australia

    Graham Johnson, Australia

  • Brigitte Wernli, Switzerland

    Brigitte Wernli, Switzerland

  • Patrick Shuma, Kenya

    Patrick Shuma, Kenya

  • Wiebke Braach, Germany

    Wiebke Braach, Germany

  • Hanne Stenmose, Denmark

    Hanne Stenmose, Denmark

  • Susan Anderson, USA

    Susan Anderson, USA

  • John Sweeney, USA

    John Sweeney, USA

  • Jan Zuring, Netherlands

    Jan Zuring, Netherlands

  • Maurice LeClerc, Canada

    Maurice LeClerc, Canada

  • Semra Gokalp, Turkey

    Semra Gokalp, Turkey

  • Michael Lee, Australia

    Michael Lee, Australia

  • Mike Rannie, Canada

    Mike Rannie, Canada

  • Jon Newsome, USA

    Jon Newsome, USA

  • Andrietta, Italy

    Andrietta, Italy
    Andrietta

  • Frank Taylor, USA

    Frank Taylor, USA

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • Malcolm Buck, Australia

    Malcolm Buck, Australia

  • Natalya Rybakova, Russia

    Natalya Rybakova, Russia

  • Yannick Richard, Canada

    Yannick Richard, Canada
    yannickrichard

  • Gudjon Sigurdsson, Iceland

    Gudjon Sigurdsson, Iceland

  • Manuel Arn, Switzerland

    Manuel Arn, Switzerland

  • Anthony Lynch, Australia

    Anthony Lynch, Australia

  • Federica Mastrosimone, Italy

    Federica Mastrosimone, Italy

  • Charlie Dourney, USA

    Charlie Dourney, USA

Learn more about the March of Faces

Coronavirus (COVID-19) Resources

Instructions

First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

If you have already registered, please use the details provided to log in using this form.

Drugs No Longer in Development

  • AMX0035
  • Reldesemtiv
  • Arimoclomol
  • TUDCA

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login